tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2021 Jul 24;8(7)
fab244.
doi: 10.1093/ofid/ofab244. eCollection 2021 Jul.
Cohabitation With a Known Coronavirus Disease 2019 Case Is Associated With Greater Antibody Concentration and Symptom Severity in a Community-Based Sample of Seropositive Adults
Joshua M Schrock[SUP] 1 2 3 [/SUP], Daniel T Ryan[SUP] 1 2 [/SUP], Rana Saber[SUP] 1 2 [/SUP], Nanette Benbow[SUP] 4 [/SUP], Lauren A Vaught[SUP] 5 6 [/SUP], Nina Reiser[SUP] 5 6 [/SUP], Matthew P Velez[SUP] 5 6 [/SUP], Ryan Hsieh[SUP] 5 6 [/SUP], Michael Newcomb[SUP] 1 2 [/SUP], Alexis R Demonbreun[SUP] 5 7 [/SUP], Brian Mustanski[SUP] 1 2 [/SUP], Elizabeth M McNally[SUP] 5 6 8 [/SUP], Richard D'Aquila[SUP] 9 [/SUP], Thomas W McDade[SUP] 3 10 [/SUP]
Affiliations
Abstract
In a community-based sample of seropositive adults (n = 1101), we found that seropositive individuals who lived with a known coronavirus disease 2019 (COVID-19) case exhibited higher blood anti-severe acute respiratory syndrome coronavirus 2 spike receptor-binding domain immunoglobulin G concentrations and greater symptom severity compared to seropositive individuals who did not live with a known COVID-19 case.
Keywords: immunity; severe acute respiratory syndrome coronavirus 2; transmission.
. 2021 Jul 24;8(7)
fab244.doi: 10.1093/ofid/ofab244. eCollection 2021 Jul.
Cohabitation With a Known Coronavirus Disease 2019 Case Is Associated With Greater Antibody Concentration and Symptom Severity in a Community-Based Sample of Seropositive Adults
Joshua M Schrock[SUP] 1 2 3 [/SUP], Daniel T Ryan[SUP] 1 2 [/SUP], Rana Saber[SUP] 1 2 [/SUP], Nanette Benbow[SUP] 4 [/SUP], Lauren A Vaught[SUP] 5 6 [/SUP], Nina Reiser[SUP] 5 6 [/SUP], Matthew P Velez[SUP] 5 6 [/SUP], Ryan Hsieh[SUP] 5 6 [/SUP], Michael Newcomb[SUP] 1 2 [/SUP], Alexis R Demonbreun[SUP] 5 7 [/SUP], Brian Mustanski[SUP] 1 2 [/SUP], Elizabeth M McNally[SUP] 5 6 8 [/SUP], Richard D'Aquila[SUP] 9 [/SUP], Thomas W McDade[SUP] 3 10 [/SUP]
Affiliations
- PMID: 34316503
- PMCID: PMC8302857
- DOI: 10.1093/ofid/ofab244
Abstract
In a community-based sample of seropositive adults (n = 1101), we found that seropositive individuals who lived with a known coronavirus disease 2019 (COVID-19) case exhibited higher blood anti-severe acute respiratory syndrome coronavirus 2 spike receptor-binding domain immunoglobulin G concentrations and greater symptom severity compared to seropositive individuals who did not live with a known COVID-19 case.
Keywords: immunity; severe acute respiratory syndrome coronavirus 2; transmission.